Since PACAP and its receptors may mediate opposing effects in the different pathophysiological conditions such as migraine, post-traumatic stress disorder, ischemia, Alzheimer’s disease, cancers, and inflammation (Denes et al., 2019). Here, ADCYAP1 is linked to migraine disorder.